文献速递消化道肿瘤与早癌消化内镜

符合遗传性弥漫型胃癌标准的患者一级亲属筛查性胃镜检查结果

Outcomes of screening gastroscopy in first-degree relatives of patients fulfilling hereditary diffuse gastric cancer criteria.
PubMed 文献 · Gastrointest Endosc · 2017-04-25

这项在荷兰2个专家中心开展的回顾性观察性队列研究,纳入来自40个符合国际遗传性弥漫型胃癌(HDGC)标准家庭的90名一级亲属,分析内镜筛查的检出情况。2004至2016年间,4人(4%)检出局限于黏膜的印戒细胞癌(pT1a),1人诊断为晚期低黏附性胃癌,38人(42%)有肠化生,4人(4%)有低级别异型增生。作者认为,在无致病性CDH1突变的HDGC家庭中进行内镜筛查可能合理,但筛查标准和频率可能需要重新考虑。

要点

  • 90名一级亲属中4人(4%)检出局限于黏膜的印戒细胞癌(pT1a),均来自1个家庭。
  • 该家庭随后被诊断存在生殖系CTNNA1突变,另1个家庭1人诊断为晚期低黏附性胃癌。
  • 38人(42%)检出肠化生,4人(4%)检出低级别异型增生,40人(44%)胃黏膜见瘢痕组织。

核心结论

  • 在无致病性CDH1突变的HDGC家庭中,内镜筛查可能合理,因为筛查检出印戒细胞癌的比例为6%。
  • 作者认为筛查标准和频率可能需要重新考虑。

研究设计与样本

  • 回顾性观察性队列研究,在荷兰2个专家中心收集符合国际HDGC标准家庭的一级亲属中接受内镜筛查者的数据。
  • 2004至2016年间,共90人(40%为男性;平均年龄48岁)来自40个家庭接受内镜筛查。
  • 每人平均接受3次内镜检查,平均随访46个月,平均内镜间隔20个月。

主要发现

  • 4人(4%)检出局限于黏膜的印戒细胞癌(pT1a),来自1个家庭,该家庭随后被诊断存在生殖系CTNNA1突变。
  • 1人来自另1个家庭,诊断为晚期低黏附性胃癌。
  • 38人(42%)诊断为肠化生,4人(4%)诊断为低级别异型增生。
  • 40人(44%)胃黏膜观察到瘢痕组织,可能妨碍内镜检出HDGC典型的小白病灶。

关键数值与推荐

  • 筛查对象为符合国际HDGC标准家庭的一级亲属。
  • 内镜筛查包括胃镜广泛检查胃部,并取随机和/或靶向胃活检标本以识别弥漫型胃癌。

临床怎么用

  • 作者认为,在无致病性CDH1突变的HDGC家庭中内镜筛查可能合理。
  • 作者认为筛查标准和频率可能需要重新考虑。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: The aim of this study was to determine the yield of endoscopic screening in first-degree relatives (FDRs) of CDH1-negative hereditary diffuse-type gastric cancer (HDGC) patients. METHODS: In this retrospective observational cohort study, in 2 expert centers in the Netherlands data were collected on FDRs from families fulfilling the international HDGC criteria that underwent endoscopic screening. Extensive inspection of the stomach was performed by gastroscopy, taking random and/or targeted stomach biopsy specimens to identify diffuse-type gastric cancer. RESULTS: Between 2004 and 2016, 90 persons (40% men; mean age, 48 years) from 40 families were offered endoscopic screening. The mean number of endoscopies per person was 3. The mean follow-up time was 46 months and mean endoscopic interval 20 months. Signet ring cell carcinoma foci restricted to the mucosa (pT1a) were identified in 4 persons (4%) from 1 family, which afterward was diagnosed with a germline CTNNA1 mutation. Advanced poorly cohesive gastric carcinoma was diagnosed in 1 person from another family. Intestinal metaplasia was diagnosed in 38 persons (42%) and low-grade dysplasia in 4 persons (4%). Additionally, in 40 persons (44%) scar tissue was observed in the gastric mucosa, which can hinder the endoscopic detection of small white lesions typical for HDGC. CONCLUSIONS: Endoscopic screening in HDGC families without a pathogenic CDH1 mutation may be reasonable, as we detected signet ring cell carcinomas in 6% of persons screened. However, the criteria and frequency of screening may have to be reconsidered.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. van der Post RS, van Dieren J, Grelack A, et al. Outcomes of screening gastroscopy in first-degree relatives of patients fulfilling hereditary diffuse gastric cancer criteria. Gastrointest Endosc. 2017. PMID: 28455161. doi:10.1016/j.gie.2017.04.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。